D.E. Shaw & Co’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $4.16M | Sell |
|
|||||
|
2024
Q3 | $10M | Buy |
|
|||||
|
2024
Q2 | $278K | Sell |
|
|||||
|
2024
Q1 | $1.47M | Sell |
|
|||||
|
2023
Q4 | $3.62M | Sell |
|
|||||
|
2023
Q3 | $8.97M | Sell |
|
|||||
|
2023
Q2 | $50.9M | Sell |
|
|||||
|
2023
Q1 | $73.8M | Buy |
|
|||||
|
2022
Q4 | $24.7M | Sell |
|
|||||
|
2022
Q3 | $39.7M | Buy |
|
|||||
|
2022
Q2 | $11.3M | Sell |
|
|||||
|
2022
Q1 | $16.5M | Buy |
|
|||||
|
2021
Q4 | $8.55M | Buy |
|
|||||
|
2021
Q3 | $257K | Sell |
|
|||||
|
2021
Q2 | $1.43M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $253K | Sell |
|
|||||
|
2020
Q3 | $794K | Buy |
|
|||||
|
2020
Q2 | $271K | Sell |
|
|||||
|
2020
Q1 | $182K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $281K | Sell |
|
|||||
|
2019
Q1 | $469K | Sell |
|
|||||
|
2018
Q4 | $2.02M | Buy |
|
|||||
|
2018
Q3 | $1.62M | Sell |
|
|||||
|
2018
Q2 | $2.14M | Buy |
|
|||||
|
2018
Q1 | $286K | Sell |
|
|||||
|
2017
Q4 | $1.58M | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $222K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $954K | Sell |
|
|||||
|
2015
Q4 | $5.46M | Buy |
|
|||||
|
2015
Q3 | $756K | Sell |
|
|||||
|
2015
Q2 | $1.34M | Buy |
|